The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Drug interactions with smoking
Abstract
PURPOSE: The mechanisms for drug interactions with smoking and clinically significant pharmacokinetic and pharmacodynamic drug interactions with smoking are reviewed. SUMMARY: Polycyclic aromatic hydrocarbons (PAHs) are some of the major lung carcinogens found in tobacco smoke. PAHs are potent inducers of the hepatic cytochrome P-450 (CYP) isoenzymes 1A1, 1A2, and, possibly, 2E1. After a person quits smoking, an important consideration is how quickly the induction of CYP1A2 dissipates. The primary pharmacokinetic interactions with smoking occur with drugs that are CYP1A2 substrates, such as caffeine, clozapine, fluvoxamine, olanzapine, tacrine, and theophylline. Inhaled insulin's pharmacokinetic profile is significantly affected, peaking faster and reaching higher concentrations in smokers compared with nonsmokers, achieving significantly faster onset and higher insulin levels. The primary pharmacodynamic drug interactions with smoking are hormonal contraceptives and inhaled corticosteroids. The most clinically significant interaction occurs with combined hormonal contraceptives. The use of hormonal contraceptives of any kind in women who are 35 years or older and smoke 15 or more cigarettes daily is considered contraindicated because of the increased risk of serious cardiovascular adverse effects. The efficacy of inhaled corticosteroids may be reduced in patients with asthma who smoke. CONCLUSION: Numerous drug interactions exist with smoking. Therefore, smokers taking a medication that interacts with smoking may require higher dosages than nonsmokers. Conversely, upon smoking cessation, smokers may require a reduction in the dosage of an interacting medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,321
Drug Interactions with Tobacco Smoking: An Update
Zevin, S., & Benowitz, N. L. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00004 · Cited by 692
Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma
Chalmers, G. W. (2002) · Thorax · doi:10.1136/thorax.57.3.226 · Cited by 545
Hoffmann, D., Djordjevic, M. V., & Hoffmann, I. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0183 · Cited by 421
Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma
Tomlinson, J. E. M. (2005) · Thorax · doi:10.1136/thx.2004.033688 · Cited by 277
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking*1
FABER, M. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.04.003 · Cited by 250
Fulton, B., & Goa, K. L. (1997) · Drugs · doi:10.2165/00003495-199753020-00007 · Cited by 250
Safety concerns and health benefits associated with oral contraception
Burkman, R., Schlesselman, J. J., & Zieman, M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.01.061 · Cited by 192
Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing.
Nemeroff, C. B., Kinkead, B. L., & Goldstein, J. M. (2002) · PubMed · Cited by 187
Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age
Häring, C., Meise, U., Humpel, C., Saria, A., Fleischhacker, W. W., & Hinterhuber, H. (1989) · Psychopharmacology · doi:10.1007/bf00442557 · Cited by 182
Carrillo, J. A., Herráiz, A. G., Ramos, S. I., Gervasini, G., Vizcaíno, S., & Benítez, J. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00003 · Cited by 177
The Role of Nicotine in Smoking-Related Cardiovascular Disease
Benowitz, N. L. (1997) · Preventive Medicine · doi:10.1006/pmed.1997.0175 · Cited by 170
Gex-Fabry, M., Balant-Gorgia, A. E., & Balant, L. P. (2003) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200302000-00007 · Cited by 167
The Impact of Smoking on Inhaled Insulin
Himmelmänn, A., JENDLE, J. H., Mellén, A., Petersen, A. H., Dahl, U., & Wollmer, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.677 · Cited by 128
Heparin kinetics: Variables related to disposition and dosage
Cipolle, R. J., Seifert, R. D., Neilan, B. A., Zaske, D. E., & Haus, E. (1981) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1981.53 · Cited by 126
Heinemann, L. A. J., Assmann, A., DoMinh, T., & Garbe, E. (1999) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625189909064007 · Cited by 126
Psychopharmacology: Atypical Antipsychotic Dosing: The Effect of Smoking and Caffeine
de León, J. (2004) · Psychiatric Services · doi:10.1176/appi.ps.55.5.491 · Cited by 115
Low-Dose Oral Contraceptive Use and the Risk of Myocardial Infarction
Rosenberg, L. A., Palmer, J. R., Rao, S. R., & Shapiro, S. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.8.1065 · Cited by 103
Epidemiology of Oral Contraceptives and Cardiovascular Disease
Chasan‐Taber, L., & Stampfer, M. J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-6-199803150-00008 · Cited by 96
Effect of cigarette smoking on fluvoxamine pharmacokinetics in humans
Spigset, O., Carleborg, L., Hedenmalm, K., & Dahlqvist, R. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90052-7 · Cited by 93
Exploring the relationship between depression and erectile dysfunction in aging men.
Seidman, S. N. (2002) · PubMed · Cited by 86
Özdemir, V., KALOW, W., Posner, P., Collins, E. J., Kennedy, J. L., Tang, B.-K., Albers, L. J., Reist, C., Roy, R., Walkes, W., et al. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00007 · Cited by 85
The Effect of Smoking Cessation and Subsequent Resumption on Absorption of Inhaled Insulin
Becker, R. H. A., Sha, S., Frick, A. D., et al. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1913 · Cited by 79
A pilot study of plasma caffeine concentrations in a US sample of smoker and nonsmoker volunteers
de Leon, J., Diaz, F. J., Rogers, T., Browne, D., Dinsmore, L., Ghosheh, O. H., Dwoskin, L. P., & Crooks, P. A. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00348-2 · Cited by 77
Cigarette Abstinence, Nicotine Gum, and Theophylline Disposition
Lee, B. L., BENOWITZ, N. L., & JACOB, P. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-4-553 · Cited by 63
Schwingl, P. J., Ory, H. W., & Visness, C. M. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70182-1 · Cited by 62
Prescribing Oral Contraceptives for Women Older Than 35 Years of Age
Seibert, C. S., Barbouche, E., Fagan, J. M., Myint, E., Wetterneck, T. B., & Wittemyer, M. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00013 · Cited by 39
Oral contraceptives and smoking, current considerations: Recommendations of a consensus panel
Schiff, I., Bell, W. R., Davis, V., Kessler, C. M., Meyers, C. M., Nakajima, S. T., & Sexton, B. J. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70700-3 · Cited by 29
Gerstenberg, G., Aoshima, T., Fukasawa, T., Yoshida, K., Takahashi, H., Higuchi, H., Murata, Y., Shimoyama, R., Ohkubo, T., Shimizu, T., et al. (2003) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200308000-00008 · Cited by 26
Interaction between Fluvoxamine and Cotinine or Caffeine
Yoshimura, R., Ueda, N., Nakamura, J., Eto, S., & Matsushita, M. (2002) · Neuropsychobiology · doi:10.1159/000048670 · Cited by 12
Lack of Effect of Withdrawal from Cigarette Smoking on Theophylline Pharmacokinetics
Eldon, M. A., Luecker, P. W., MacGee, J., et al. (1987) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1987.tb02189.x · Cited by 6
Cited by
Factors affecting the development of adverse drug reactions (Review article)
Alomar, M. J. (2014) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2013.02.003 · Cited by 484
Zhou, S.-F., Wang, B., Yang, L.-P., & Liu, J.-P. (2010) · Drug Metabolism Reviews · doi:10.3109/03602530903286476 · Cited by 262
Hernigou, J., & Schuind, F. (2019) · Bone & Joint Research · doi:10.1302/2046-3758.86.bjr-2018-0344.r1 · Cited by 109
Smoking cessation interventions and older adults
Doolan, D. M., & Froelicher, E. S. (2008) · Progress in Cardiovascular Nursing · doi:10.1111/j.1751-7117.2008.00001.x · Cited by 85
Effects of nicotine withdrawal on cognition in a clinical trial setting
Wesnes, K. A., Edgar, C. J., Kezic, I., Salih, H. M., & de Boer, P. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3089-6 · Cited by 31
Metadata
- Authors
- Kroon, L. A.
- Venue
- American Journal of Health-System Pharmacy
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-09-15
- Volume
- 64
- Issue
- 18
- Pages
- 1917-1921
- ISSN
- 1079-2082 (ISSN-L)
- 1535-2900
- OpenAlex
- W1964552738
- Cited by
- 345
- References
- 31
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.